Cargando…

Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens

Detalles Bibliográficos
Autores principales: Hanada, Ken-ichi, Chow, Christopher, Hoyos, Raul Gil, Gartner, Jared J, Prickett, Todd D, Somerville, Robert, Hogan, Katherine, Robbins, Paul F, Rosenberg, Steven A, Yang, James C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646102/
http://dx.doi.org/10.1186/2051-1426-3-S2-P20
_version_ 1782400914843238400
author Hanada, Ken-ichi
Chow, Christopher
Hoyos, Raul Gil
Gartner, Jared J
Prickett, Todd D
Somerville, Robert
Hogan, Katherine
Robbins, Paul F
Rosenberg, Steven A
Yang, James C
author_facet Hanada, Ken-ichi
Chow, Christopher
Hoyos, Raul Gil
Gartner, Jared J
Prickett, Todd D
Somerville, Robert
Hogan, Katherine
Robbins, Paul F
Rosenberg, Steven A
Yang, James C
author_sort Hanada, Ken-ichi
collection PubMed
description
format Online
Article
Text
id pubmed-4646102
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46461022015-11-20 Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens Hanada, Ken-ichi Chow, Christopher Hoyos, Raul Gil Gartner, Jared J Prickett, Todd D Somerville, Robert Hogan, Katherine Robbins, Paul F Rosenberg, Steven A Yang, James C J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646102/ http://dx.doi.org/10.1186/2051-1426-3-S2-P20 Text en Copyright © 2015 Hanada et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Hanada, Ken-ichi
Chow, Christopher
Hoyos, Raul Gil
Gartner, Jared J
Prickett, Todd D
Somerville, Robert
Hogan, Katherine
Robbins, Paul F
Rosenberg, Steven A
Yang, James C
Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
title Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
title_full Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
title_fullStr Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
title_full_unstemmed Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
title_short Personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
title_sort personalized immunotherapy for non-small cell lung cancer through identification of tumor-specific mutations by next generation sequencing and adoptive transfer of tumor infiltrating lymphocytes that recognize neoantigens
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646102/
http://dx.doi.org/10.1186/2051-1426-3-S2-P20
work_keys_str_mv AT hanadakenichi personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT chowchristopher personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT hoyosraulgil personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT gartnerjaredj personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT pricketttoddd personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT somervillerobert personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT hogankatherine personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT robbinspaulf personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT rosenbergstevena personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens
AT yangjamesc personalizedimmunotherapyfornonsmallcelllungcancerthroughidentificationoftumorspecificmutationsbynextgenerationsequencingandadoptivetransferoftumorinfiltratinglymphocytesthatrecognizeneoantigens